Embla Medical hf 2020 AR2
The report outlines Össur's financial and sustainability performance for the fiscal year 2020. Despite challenges from the COVID-19 pandemic, the company achieved an EBITDA margin of 15% and generated USD 119 million in cash from operations. In sustainability, Össur announced its commitment to becoming carbon neutral in 2021 for Scope 1, Scope 2, and selected Scope 3 emissions. Key achievements in 2020 included recycling 65% of waste, maintaining a 46% female workforce, and reaching 36% female representation in management.
Company: Embla Medical hf
Sector: Health Care
Country: Iceland
Year: 2020
Type: AR2
Pages: 126
Embla Medical hf
Annual Report
The report outlines Össur's financial and sustainability performance for the fiscal year 2020. Despite challenges from the COVID-19 pandemic, the company achieved an EBITDA margin of 15% and generated USD 119 million in cash from operations. In sustainability, Össur announced its commitment to becoming carbon neutral in 2021 for Scope 1, Scope 2, and selected Scope 3 emissions. Key achievements in 2020 included recycling 65% of waste, maintaining a 46% female workforce, and reaching 36% female representation in management.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Women on Board
Women in Management
Employees